3 Stocks That Could Be the Next Biotech Buyouts
Biotech investors are on the edge of their seats this holiday season thanks to a recent string of juicy buyout offers. Despite a busy year for acquisitions, big pharmaceutical companies with pipelines to fill and money to spend have been jumping over each other to acquire smaller biotechs at steep premiums.
Which of today's smaller biotechs will be the next one that inspires pharmaceutical giants to open their checkbooks wide? Arrowhead Pharmaceuticals (NASDAQ: ARWR), Blueprint Medicines (NASDAQ: BPMC), and Deciphera Pharmaceuticals (NASDAQ: DCPH) are on big pharma's Christmas list. Here's why.
Image source: Getty Images.
Source Fool.com
